81
Pharma & HealthcareStrong Buy
HDFC Pharma And Healthcare
HDFC · Direct–Growth · rank #1 of 18 by Smart Score
Trailing returns
1 Year
19.3%
+18.8% vs index
3 Years
—
5 Years
—
Since launch
31.8%
Year-by-year performance
2024
+52.2%+36.6% vs index
2025
+2.4%-5.3% vs index
2026
+21.5%+23.2% vs index
Why this score
HDFC Pharma And Healthcare scores 81/100 — the top-rated Pharma & Healthcare fund of 18 (Strong Buy). It stands out for sharpe ratio and alpha — beating 97% of peers on sharpe ratio. It has no major weak spot vs the category.
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio1.79 · 97th percentile in category
Alpha20.36 · 97th percentile in category
Sortino ratio2.56 · 97th percentile in category
Volatility14.19 · 79th percentile in category
1Y return19.29% · 97th percentile in category
Fund size2611.33 Cr · 69th percentile in category